propranolol has been researched along with Basal Ganglia Diseases in 11 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was no clear difference regarding efficacy between flunarizine and betahistine in the vertigo study." | 7.69 | Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| " There was no clear difference regarding efficacy between flunarizine and betahistine in the vertigo study." | 3.69 | Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| "Propranolol was somewhat better than flunarizine in reducing the severity of migraine attacks, although this may have been due to a selection bias." | 2.68 | Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. ( Amery, WK; De Locht, P; Verspeelt, J, 1996) |
| " In the antipsychotic classification, special attention is given to side effects (extrapyramidal motor signs, tardive dyskinesias, akathisis) and to dosage for the elderly." | 1.25 | Observations on the psychopharmacology of the aged. ( Eisdorfer, C, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (81.82) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilbur, R | 1 |
| Kulik, FA | 1 |
| Chaudhry, R | 1 |
| Radonjic, D | 1 |
| Waters, B | 1 |
| Verspeelt, J | 2 |
| De Locht, P | 2 |
| Amery, WK | 2 |
| Gabriel, E | 1 |
| Karobath, M | 1 |
| Lenz, G | 1 |
| Kudrin, AN | 1 |
| Davydova, ON | 1 |
| Krendal', FP | 1 |
| Elizur, A | 1 |
| Segal, S | 1 |
| Yeret, A | 1 |
| Ben-David, M | 1 |
| Eisdorfer, C | 1 |
| Beasley, BA | 1 |
| Ford, DH | 1 |
| Keepers, GA | 1 |
| Casey, DE | 1 |
| Gelenberg, AJ | 1 |
3 reviews available for propranolol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Aging and the extrapyramidal system.
Topics: Aged; Aging; Basal Ganglia Diseases; Chlorpromazine; Chorea; Dopamine; Frontal Lobe; Gait; Haloperid | 1976 |
Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Akathisia, Drug-Induced; Amantadine; Antipsychotic Ag | 1986 |
Treating extrapyramidal reactions: some current issues.
Topics: Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Humans | 1987 |
1 trial available for propranolol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Basal Ganglia Diseases; Belgium; Child; Cohort Studies; | 1996 |
7 other studies available for propranolol and Basal Ganglia Diseases
| Article | Year |
|---|---|
Propranolol (Inderal) for tardive dyskinesia and extrapyramidal side effects from neuroleptics: possible involvement of beta-adrenergic mechanisms.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Humans; | 1980 |
Efficacy of propranolol in a patient with tardive dyskinesia and extrapyramidal syndrome.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Drug Therapy, Combination; Dys | 1982 |
Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
Topics: Basal Ganglia Diseases; Betahistine; Cohort Studies; Depression; Female; Flunarizine; Histamine H1 A | 1996 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug | 1976 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Ag | 1977 |
Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Male; Prolactin; Propranolol; Schizoph | 1979 |
Observations on the psychopharmacology of the aged.
Topics: Aged; Amantadine; Antidepressive Agents; Antipsychotic Agents; Basal Ganglia Diseases; Butyrophenone | 1975 |